Sarepta Therapeutics, Inc. technical analysis
Technical analysis of Sarepta Therapeutics, Inc. (stock) with the Montbon Method — Elliott Waves, moving averages and a 0–100 score.
What is Sarepta Therapeutics, Inc.
Sarepta Therapeutics is a biopharmaceutical company that develops RNA-targeted therapies, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. The company commercializes drugs for Duchenne muscular dystrophy (EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS) and develops additional therapeutic programs in clinical trials. It was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.
Description generated automatically from public sources; it may be inaccurate or out of date.
Sarepta Therapeutics, Inc.: latest session data
Closing values for October 20, 2026, computed on the last 12 months of prices.
Moving averages
21 sessions
18.01 $
+5.47%
50 sessions
19.23 $
−1.21%
200 sessions
18.88 $
+0.65%
Session levels
s2
16.85
Support
s1
17.29
Support
pivot
17.56
Pivot
r1
18.00
Resistance
r2
18.27
Resistance
How to read it
In the October 20, 2026 session Sarepta Therapeutics, Inc. closed higher at 19.00 $, +7.16% versus the previous session.
The price sits mixed against its moving averages: +5.47% against the 21-session average, −1.21% against the 50 and +0.65% against the 200.
The 14-period RSI reads 54.5, in neutral territory.
MACD stands at -0.440 against a signal line at -0.559: the histogram is positive (+0.119).
ADX reads 15.1, indicating weak directionality.
Levels computed on the latest session place supports at 17.29 and 16.85 $ and resistances at 18.00 and 18.27 $, around a pivot of 17.56.
The average daily range (ATR) is 0.992 $, or 5.22% of price.
Turnover was 714.2K shares, 24% of the 20-session average.
Over the last twelve months the price ranged between 14.68 and 23.62 $, and today stands −19.56% from the period high.
Measures computed on closing prices. They describe the past; they are not forecasts.
Score, Elliott Waves, moving averages and technical indicators — free, no card
If you're not registered we'll ask you to sign in (free), then open the SRPT analysis.
How Montbon’s technical analysis works
Montbon analyses markets with Elliott Waves, multi-timeframe moving averages and a 0–100 score summarising the technical setup. It is an informational screening tool.
Elliott Waves
Wave counting to frame the price structure.
MTF moving averages
Moving averages across timeframes to read the trend.
0–100 score
A technical summary of the setup, updated daily.
FAQ about Sarepta Therapeutics, Inc.
How is Sarepta Therapeutics, Inc. analysed technically?
Technical analysis of Sarepta Therapeutics, Inc. is based on price charts and indicators such as moving averages, RSI and MACD, to observe trend, momentum and volatility across different time horizons.
Which timeframes are used for Sarepta Therapeutics, Inc.?
The daily and weekly charts are typically used for medium-to-long-term trends, while intraday charts (for example 1-hour or 15-minute) are used for short-term movements.
What are Elliott Waves applied to Sarepta Therapeutics, Inc.?
Elliott Wave theory describes price moves as sequences of impulsive and corrective waves; applied to Sarepta Therapeutics, Inc. it helps frame the technical structure of the historical chart and is not a forecast.
Other tickers to analyse
Disclaimer. For informational purposes only; not financial advice or a recommendation. Montbon Analytics is not an authorised financial intermediary.
Are you an issuer and want a correction or removal? Write to info@montbon.com.